- Home
- PLRX
as 06-02-2025 11:39am EST
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | SOUTH SAN FRANCISCO |
| Market Cap: | 84.7M | IPO Year: | 2020 |
| Target Price: | $9.79 | AVG Volume (30 days): | 1.0M |
| Analyst Decision: | Hold | Number of Analysts: | 10 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.61 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.10 - $16.10 | Next Earning Date: | 05-08-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | -57.14% |
Latest Pliant Therapeutics Inc. News
PLRX Breaking Stock News: Dive into PLRX Ticker-Specific Updates for Smart Investing
GlobeNewswire
12 days ago
Pliant Therapeutics Presents Clinical and Preclinical Data at the American Thoracic Society International Conference
GlobeNewswire
25 days ago
Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results
Clinical Trials Arena
a month ago
Pliant cuts workforce by 45% following lung trial termination
MT Newswires
a month ago
Pliant Therapeutics to lay off 45% of Workforce in Restructuring Move
BioPharma Dive
a month ago
Cytokinetics reveals unexpected delay; AstraZeneca combo therapy hits in asthma
GlobeNewswire
a month ago
Pliant Therapeutics Announces Strategic Realignment of Workforce and Operations
Zacks
2 months ago
PLIANT THERAPT (PLRX) Upgraded to Buy: Here's What You Should Know
GlobeNewswire
2 months ago
Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference
Compare PLRX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PLRX Pliant Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.